health
1 min read
Senate Panel Recommends Contempt Charges for Fauci
A U.S. Senate committee has voted to recommend holding Dr. Anthony Fauci in contempt of Congress. The Republican-led panel seeks a Justice Department charge following Fauci's testimony regarding COVID-19 origins. This action follows an investigation into the pandemic's beginnings.
09/24/2026 · Geneva County edition
Advertisement
Advertisement
Why it matters locally: The Justice Department's decision on whether to pursue contempt charges against Dr. Fauci could have implications for public health policy and federal investigations, which indirectly affect all states, including Alabama.
WASHINGTON – A U.S. Senate committee voted to recommend holding Dr. Anthony Fauci in contempt of Congress. The Republican-led panel advanced the contempt referral to the Justice Department. This action follows an investigation into the origins of COVID-19. The Senate Select Subcommittee on the Coronavirus Pandemic conducted the vote. The committee seeks a charge of contempt against Fauci related to his testimony and cooperation with the panel's inquiry. The contempt recommendation means the committee formally requests the Justice Department to pursue legal action against Fauci. The department will then decide whether to bring charges. Fauci served as the Director of the National Institute of Allergy and Infectious Diseases (NIAID) for 38 years. He also acted as the Chief Medical Advisor to seven U.S. presidents. His tenure at NIAID concluded in December 2022. The committee's action stems from its ongoing probe into the COVID-19 pandemic. The investigation has focused on the virus's emergence and the U.S. government's response.Related Topics
Editorial Transparency
AI-Generated · Written by National DeskArticle Ratings
Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0
How do you feel about this story?
NA
National Desk
Trust 3.1104047 articles8,231,170 views75% fact accuracy
View ProfileSign in to follow this author from their profile.

Discussion (0)
Join the Conversation
Join the conversation
Sign in to share your thoughts, reply to readers, and like comments.
No comments yet. Be the first to comment!